博瑞生物医药（苏州）股份有限公司关于“博瑞转债”2025年付息的公告

Group 1 - The company, Borui Biopharmaceutical (Suzhou) Co., Ltd., will begin paying interest on its convertible bonds, "Borui Convertible Bonds," on January 5, 2026, for the period from January 4, 2025, to January 3, 2026 [2][4] - The total amount of convertible bonds issued is 46.5 million yuan, with a face value of 100 yuan per bond, and the bonds have a six-year term from January 4, 2022, to January 3, 2028 [2][16] - The interest rates for the bonds are structured to increase over the years, starting at 0.4% in the first year and reaching 3% in the sixth year [2][4] Group 2 - The interest payment for the fourth year will be at a rate of 1.5%, resulting in a payment of 15 yuan per bond (tax included) [8] - The bondholders will be registered as of December 31, 2025, and the interest will be paid on January 5, 2026 [9][10] - The company has established a process for interest payment through a designated clearing company, which will handle the distribution of interest to bondholders [10] Group 3 - The convertible bonds can be converted into shares from July 11, 2022, to January 3, 2028, with an initial conversion price of 35.68 yuan per share, which has been adjusted to 34.74 yuan per share [3][17] - The company has outlined redemption terms for the bonds, including conditions under which the company may redeem the bonds at 115% of the face value [19][20] - The company has indicated that the redemption clause may be triggered if the stock price meets certain conditions, specifically if it remains above 130% of the conversion price for a specified number of trading days [20][21]